Open AccessLetter in response to “Cherry‐picking of evidence fails to accurately show extent of overdiagnosis: Mammographic screening harms understated”
Author(s) -
Lee Warwick,
Peters Gudrun
Publication year - 2013
Publication title -
journal of medical radiation sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.484
H-Index - 18
eISSN - 2051-3909
pISSN - 2051-3895
DOI - 10.1002/jmrs.11
Subject(s) - overdiagnosis , medicine , breast cancer , breast cancer screening , mammography , family medicine , cancer , pathology
The findings of the Independent Breast Screening Review (IBSR) by the Independent UK Panel on Breast Cancer Screening, led by Prof. Sir Michael Marmot, have been published subsequent to the review by Lee and Peters. The key findings of the IBSR “suggested a 20% reduction in mortality in women invited to participate in a 20‐year screening programme” and that “1 breast cancer death was averted for every 235 women invited to screening and 1 death averted for every 180 women who attend screening.” This review cannot be accused of “cherry‐picking” evidence with regard to mammographic screening. An editorial in Lancet, commenting on the IBSR, states that the review should begin to lay the benefits versus harm controversy to rest.